Strides Arcolab trades in green amidst sluggish market trend

22 Sep 2011 Evaluate

Strides Arcolab is currently trading at Rs 339.85, up by 0.55 points or 0.16% from its previous closing of Rs 339.30 on the BSE.

The scrip opened at Rs 339.00 and has touched a high and low of Rs 351.20 and Rs 328.00 respectively. So far 664896 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 477.75 on 09-Nov-2010 and a 52 week low of Rs 276.25 on 22-Aug-2011.

Last one week high and low of the scrip stood at Rs 358.00 and Rs 295.10 respectively. The current market cap of the company is Rs 1979.34 crore.

The promoters holding in the company stood at 28.16% while Institutions and Non-Institutions held 51.62% and 20.22% respectively.

Recently, Onco Therapies, a division of Agila, which is a wholly owned subsidiary of Strides Arcolab, received European Union (EU) approval for Oxaliplantin Injection 5mg/ml (10ml, 20ml and 40ml). This is the second European approval out of the 22 filings made by OTL in the year 2010 for products which have a combined market value of over $5 billion. The application for Oxaliplantin 5mg/ml was submitted through a Decentralized Procedure (DCP).

The current approval is from UK and approval for the rest of the European countries is expected shortly. The product will be manufactured at the Oncology complex in Bangalore.

Oxaliplantin is among the 37 drugs licensed to Pfizer on a semi-exclusive basis for sales in 17 European countries.

Earlier in July, Onco Therapies received United States Food and Drug Administration (US FDA) approval for Gemcitabine for Injection USP in 200mg, 1 gm and 2 gm dosage forms.

Strides Pharma Scien Share Price

1551.65 27.15 (1.78%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.